SCHEMBL6239483

SCHEMBL6239483

CC(C)(C)[Si](Oc1ccc2c(c1)ncn2-c1cc(O)c(C(=O)O)s1)(c1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 16/20 0.46
NEK2 P51955 2/20 0.44
FGFR1 P11362 4/20 0.43
PLK4 O00444 1/20 0.43
CHEK1 O14757 1/20 0.43
AURKA O14965 1/20 0.43
DAPK3 O43293 1/20 0.43
JAK2 O60674 1/20 0.43
CHEK2 O96017 1/20 0.43
INSR P06213 1/20 0.43
LCK P06239 1/20 0.43
FYN P06241 1/20 0.43
CDK1 P06493 1/20 0.43
CSF1R P07333 1/20 0.43
LYN P07948 1/20 0.43
MET P08581 1/20 0.43
PIM1 P11309 1/20 0.43
SRC P12931 1/20 0.43
FLT1 P17948 1/20 0.43
FGFR3 P22607 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5062107 0.92 PLK1 (0.46) PLK1NEK2FGFR1PLK4CHEK1
SCHEMBL5065832 0.84 PLK1 (0.46) PLK1NEK2FGFR1PLK4CHEK1
SCHEMBL3607331 0.79 PLK1 (0.48) PLK1NEK2FGFR1PLK4CHEK1
SCHEMBL5067437 0.78 PLK1 (0.68) PLK1NEK2FGFR1PLK4CHEK1
SCHEMBL5058123 0.78 PLK1 (0.55) PLK1NEK2FGFR1PLK4CHEK1
SCHEMBL5058295 0.78 PLK1 (0.55) PLK1NEK2FGFR1PLK4CHEK1
SCHEMBL5008887 0.77 PLK1 (0.61) PLK1NEK2FGFR1CSF1RPIM1
SCHEMBL3617056 0.75 FGFR1 (0.53) PLK1NEK2FGFR1PLK4CHEK1
SCHEMBL3615059 0.74 PLK1 (0.53) PLK1NEK2FGFR1PLK4CHEK1
SCHEMBL5062343 0.73 FGFR1 (0.55) PLK1NEK2FGFR1GSK3BPLK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546137-A1 BENZIMIDAZOL-1-YL-THIOPHENE COMPOUNDS FOR THE TREATMENT OF CANCER SmithKline Beecham Corporation (US) 2005-06-29 EP disclosed
WO-2004014899-A1 THIOPHENE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2004-02-19 WO disclosed